Scribe Therapeutics Inc. Share Price
NASDAQ: SCTXScribe Therapeutics Inc. Stock Performance
Scribe Therapeutics Inc. Share Price Today
As of 4 November 2026, Scribe Therapeutics Inc.'s share price is $16.23. The stock opened at $16.30, compared to its previous close of $15.54. During today's trading session, Scribe Therapeutics Inc.'s share price traded between $15.76 and $16.41, with an average price of $16.08. Over the past 52 weeks, the stock has recorded a high of $39.20 and a low of $13.51. In terms of performance, Scribe Therapeutics Inc.'s share price has declined by 15.56% over the last six months and is down 15.56% on a year-on-year basis.
Scribe Therapeutics Inc. Share Price Chart
About Scribe Therapeutics Inc.
Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.
Scribe Therapeutics Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $15.19 | $16.11 | +3.70% |
Oct 2026 | $18.87 | $15.53 | -15.76% |
Sep 2026 | $29.40 | $18.43 | -35.12% |
Aug 2026 | $19.86 | $28.41 | +47.84% |
Jul 2026 | $24.75 | $19.22 | N/A |